IQVIA HOLDINGS INC. Remaining Share Repurchase Authorization
IQVIA HOLDINGS INC. (IQV) had Remaining Share Repurchase Authorization of $889.00 million as of 2018-09-30, per its 10-Q filed 2018-10-25.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2018-10-25
- 2018-09-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $889.00M.
- 2018-06-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $1.00B.
- 2018-03-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $1.60B.
- 2015-09-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $109.50M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2018-09-30 | $889.00M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $1.00B 10-Q · filed 2018-07-27 |
| 2018-03-31 | $1.60B 10-Q · filed 2018-05-04 |
| 2015-09-30 | $109.50M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $109.50M 10-Q · filed 2015-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |